454
Views
13
CrossRef citations to date
0
Altmetric
Review

Endemic mycoses: epidemiology and diagnostic strategies

, &
Pages 1105-1117 | Received 23 Mar 2020, Accepted 03 Jul 2020, Published online: 20 Jul 2020

References

  • Lockhart SR, Guarner J. Emerging and reemerging fungal infections. Semin Diagn Pathol. 2019;36(3):177–181.
  • Salzer HJF, Burchard G, Cornely OA, et al. Diagnosis and management of systemic endemic mycoses causing pulmonary disease. Respiration. 2018;96(3): 283–301.
  • Queiroz-Telles F, Fahal AH, Falci DR, et al. Neglected endemic mycoses. Lancet Infect Dis. 2017;17(11):e367–e377.
  • Bonifaz A, Vázquez-González D, Perusquía-Ortiz AM. Endemic systemic mycoses: coccidioidomycosis, histoplasmosis, paracoccidioidomycosis and blastomycosis. J Dtsch Dermatol Ges. 2011;9(9):705‐715.
  • Brown EM, McTaggart LR, Dunn D, et al. Epidemiology and Geographic Distribution of Blastomycosis, Histoplasmosis, and Coccidioidomycosis, Ontario, Canada, 1990-2015. Emerg Infect Dis. 2018;24(7):1257–1266.
  • Molina-Morant D, Sánchez-Montalvá A, Salvador F, et al. Imported endemic mycoses in Spain: evolution of hospitalized cases, clinical characteristics and correlation with migratory movements, 1997-2014. PLoS Negl Trop Dis. 2018;12(2):e0006245.
  • Limper AH, Adenis A, Le T, et al. Fungal infections in HIV/AIDS. Lancet Infect Dis. 2017;17:e334–e343.
  • Taborda CP, Buccheri R, Benard G, et al. Paracoccidioides spp. and histoplasma capsulatum: current and new perspectives for diagnosis and treatment. Curr Top Med Chem. 2018;18(15):1333–1348.
  • Valero C, Gago S, Monteiro MC, et al. African histoplasmosis: new clinical and microbiological insights. Med Mycol. 2018;56(1):51–59.
  • Buitrago MJ, Cuenca-Estrella M. Current epidemiology and laboratory diagnosis of endemic mycoses in Spain. Enferm Infecc Microbiol Clin. 2012;30(7):407–413.
  • Wheat LJ, Azar MM, Bahr NC, et al. Histoplasmosis. Infect Dis Clin North Am. 2016;30(1):207–227.
  • Damasceno-Escoura AH, Mora DJ, Cardeal AC, et al. Histoplasmosis in HIV-infected patients: epidemiological, clinical and necropsy data from a brazilian teaching hospital. Mycopathologia. 2020;185(2):339–346.
  • Nacher M. Histoplasmosis in persons living with HIV. J Fungi (Basel). 2019;6(1):pii: E3.
  • Caceres DH, Knuth M, Derado G, et al. Diagnosis of progressive disseminated histoplasmosis in advanced HIV: A meta-analysis of assay analytical performance. J Fungi (Basel). 2019;5(3):E76.
  • Smith JA, Riddell J 4th, Kauffman CA. Cutaneous manifestations of endemic mycoses. Curr Infect Dis Rep. 2013;15(5):440–449.
  • Azar MM, Hage CA. Clinical perspectives in the diagnosis and management of histoplasmosis. Clin Chest Med. 2017;38(3):403–415.
  • Staffolani S, Buonfrate D, Angheben A, et al. Acute histoplasmosis in immunocompetent travelers: a systematic review of literature. BMC Infect Dis. 2018;18(1):673.
  • Hoenigl M, Schwetz I, Wurm R, et al. Pulmonary histoplasmosis in three Austrian travelers after a journey to Mexico. Infection. 2008;36(3):282–284.
  • Voto C, Guadalupe Pérez M, Gómez S, et al. Histoplasmosis in Argentina: case series in children. Rev Iberoam Micol. 2020;37(1):34–36.
  • Azar MM, Loyd JL, Relich RF, et al. Current concepts in the epidemiology, diagnosis, and management of histoplasmosis syndromes. Semin Respir Crit Care Med. 2020;41(1):13–30.
  • Deepe GS Jr., Sheppard DC. Outbreaks of histoplasmosis: the spores set sail. PLoS Pathog. 2018;14(9):e1007213.
  • Baddley JW, Winthrop KL, Patkar NM, et al. Geographic distribution of endemic fungal infections among older persons, United States. Emerg Infect Dis. 2011;17(9):1664–1669.
  • Hay RJ, White HS, Fields PE, et al. Histoplasmosis in the eastern Caribbean: a preliminary survey of the incidence of the infection. J Trop Med Hyg. 1981;84(1):9–12.
  • Gascón J, Torres JM, Jiménez M, et al. Histoplasmosis infection in Spanish travelers to Latin America. Eur J Clin Microbiol Infect Dis. 2005;24(12):839–841.
  • Ramón-García G, Peña-Alonso YR, Ontiveros-Nevares PG. Histoplasmosis diseminada en niños disseminated histoplasmosis in children. Bol Med Hosp Infant Mex. 1993;50(12):870–875.
  • Farina C, Rizzi M, Ricci L, et al. Imported and autochthonous histoplasmosis in Italy: new cases and old problems. Rev Iberoam Micol. 2005;22(3):169–171.
  • Pan B, Chen M, Pan W, et al. Histoplasmosis: a new endemic fungal infection in China? Review and analysis of cases. Mycoses. 2013;56(3):212–221.
  • Baker J, Setianingrum F, Wahyuningsih R, et al. Mapping histoplasmosis in South East Asia - implications for diagnosis in AIDS. Emerg Microbes Infect. 2019;8(1):1139–1145.
  • Hatakeyama S, Okamoto K, Ogura K, et al. Histoplasmosis among HIV-infected patients in Japan: a case report and literature review. Jpn J Infect Dis. 2019;72(5):330–333.
  • Patel AK, Patel KK, Toshniwal H, et al. Histoplasmosis in non-endemic North-Western part of India. Indian J Med Microbiol. 2018;36(1):61–64.
  • Oladele RO, Ayanlowo OO, Richardson MD, et al. Histoplasmosis in Africa: an emerging or a neglected disease? PLoS Negl Trop Dis. 2018 Jan 18;12(1):e0006046.
  • Myint T, Al-Hasan MN, Ribes JA, et al. Temporal trends, clinical characteristics, and outcomes of histoplasmosis in a tertiary care center in Kentucky, 2000 to 2009. J Int Assoc Provid AIDS Care. 2014;13(2):100–105.
  • Almeida MA, Almeida-Silva F, Guimarães AJ, et al. The occurrence of histoplasmosis in Brazil: A systematic review. Int J Infect Dis. 2019;86:147–156.
  • Medina N, Samayoa B, Lau-Bonilla D, et al. Burden of serious fungal infections in Guatemala. Eur J Clin Microbiol Infect Dis. 2017;36(6):965–969.
  • Adenis AA, Valdes A, Cropet C, et al. Burden of HIV-associated histoplasmosis compared with tuberculosis in Latin America: a modelling study. Lancet Infect Dis. 2018;18(10):1150–1159.
  • Sirait SP, Bramono K, Hermanto N. Correlation of CD4 counts with clinical and histopathological findings in disseminated histoplasmosis: a 10-year retrospective study. Int J Dermatol. 2017;56(9):926–931.
  • Staffolani S, Riccardi N, Farina C, et al. Acute histoplasmosis in travelers: a retrospective study in an Italian referral center for tropical diseases. Pathog Glob Health. 2020;114(1):40–45.
  • Agudelo CA, Restrepo CA, Molina DA, et al. Tuberculosis and histoplasmosis co-infection in AIDS patients. Am J Trop Med Hyg. 2012;87(6):1094–1098.
  • Soza GM, Patel M, Readinger A, et al. Disseminated cutaneous histoplasmosis in newly diagnosed HIV. Proc (Bayl Univ Med Cent). 2016;29(1):50–51.
  • Kobayashi K, Asakura T, Kawada I, et al. Disseminated histoplasmosis from a calcified lung nodule after long-term corticosteroid therapy in an elderly Japanese patient: A case report. Medicine (Baltimore). 2019;98(17):e15264.
  • Vergidis P, Avery RK, Wheat LJ, et al. Histoplasmosis complicating tumor necrosis factor-α blocker therapy: a retrospective analysis of 98 cases. Clin Infect Dis. 2015;61(3):409–417.
  • Untanu RV, Akbar S, Graziano S, et al. Histoplasmosis-induced hemophagocytic lymphohistiocytosis in an adult patient: a case report and review of the literature. Case Rep Infect Dis. 2016;2016:1358742.
  • Mittal J, Ponce MG, Gendlina I, et al. Histoplasma capsulatum: mechanisms for pathogenesis. Curr Top Microbiol Immunol. 2019;422:157–191.
  • Hove MG, Woods GL, Vergidis P. Duration of fungal culture incubation in an area endemic for Histoplasma capsulatum. Diagn Microbiol Infect Dis. 1997;28(1):41–43.
  • Zancopé-Oliveira RM, Bragg SL, Reiss E, et al. Immunochemical analysis of the H and M glycoproteins from Histoplasma capsulatum. Clin Diagn Lab Immunol. 1994;1(5):563–568.
  • López LF, Muñoz CO, Cáceres DH, et al. Standardization and validation of real time PCR assays for the diagnosis of histoplasmosis using three molecular targets in an animal model. PLoS One. 2017;12(12):e0190311.
  • Almeida MA, Damasceno LS, Pizzini CV, et al. Role of western blot assay for the diagnosis of histoplasmosis in AIDS patients from a national institute of infectious diseases in Rio de Janeiro, Brazil. Mycoses. 2019;62(3):261–267.
  • Gómez BL. Molecular diagnosis of endemic and invasive mycoses: advances and challenges. Rev Iberoam Micol. 2014;31(1):35–41.
  • Fernández Andreu CM, Martínez Machin G. The sources of histoplasmosis infection on the Isla de la Juventud, Cuba. Rev Inst Med Trop Sao Paulo. 1992;34(5):441–446.
  • Ordóñez N, Arango M, Gómez B, et al. The value of immunological assays in the diagnosis of meningeal histoplasmosis. Rev Neurol. 1997;25(145):1376–1380.
  • Libert D, Procop GW, Ansari MQ. Histoplasma urinary antigen testing obviates the need for coincident serum antigen testing. Am J Clin Pathol. 2018;149(4):362–368.
  • Queiroz-Telles F, Escuissato DL. Pulmonary paracoccidioidomycosis. Semin Respir Crit Care Med. 2011;32(6):764‐774.
  • Canteros CE. Paracoccidioidomicosis: crónica de una enfermedad olvidada [Paracoccidioidomycosis: chronicle of a neglected disease]. Med (B Aires). 2018;78(3):180–184.
  • Hahn RC, Rodrigues AM, Della Terra PP, et al. Clinical and epidemiological features of paracoccidioidomycosis due to Paracoccidioides lutzii. PLoS Negl Trop Dis. 2019;13(6):e0007437.
  • de Almeida SM, Salvador GLO, Roza TH, et al. Geographical evaluation of neuroparacoccidioidomycosis and paracoccidioidomycosis in Southern Brazil. Mycoses. 2018;61(8):587–593.
  • de Macedo PM, Almeida-Paes R, Freitas DF, et al. Acute juvenile paracoccidioidomycosis: A 9-year cohort study in the endemic area of Rio de Janeiro, Brazil. PLoS Negl Trop Dis. 2017;11(3):e0005500.
  • Abreu E Silva MÀ, Salum FG, Figueiredo MA, et al. Important aspects of oral paracoccidioidomycosis–a literature review. Mycoses. 2013;56(3):189–199.
  • Messina F, Romero M, Benchetrit A, et al. Clinical and microbiological characteristics of paracoccidioidomycosis in patients with AIDS in Buenos Aires, Argentina. Med Mycol. 2020;58(1):22–29.
  • de Almeida JN Jr, Peçanha-Pietrobom PM, Colombo AL. Paracoccidioidomycosis in immunocompromised patients: a literature review. J Fungi (Basel). 2018;5(1):pii: E2.
  • Kayser M, Rickerts V, Drick N, et al. Chronic progressive pulmonary paracoccidioidomycosis in a female immigrant from Venezuela. Ther Adv Respir Dis. 2019;13:1753466619894913.
  • Millington MA, Nishioka SA, Martins ST, et al. Paracoccidioidomicose: abordagem histórica e perspectivas de implantação da vigilância e controle [Paracoccidioidomycosis: historical approach and perspectives for implementation of surveillance and control]. Epidemiol Serv Saude. 2018;27:e0500002.
  • Barreto MM, Marchiori E, Amorim VB, et al. Thoracic paracoccidioidomycosis: radiographic and CT findings. Radiographics. 2012;32(1):71–84.
  • Morato EM, Morais GR, Sato F, et al. Morphological and structural changes in lung tissue infected by paracoccidioides brasiliensis: FTIR photoacoustic spectroscopy and histological analysis. Photochem Photobiol. 2013;89(5):1170–1175.
  • da Silva JF, de Oliveira HC, Marcos CM, et al. Advances and challenges in paracoccidioidomycosis serology caused by paracoccidioides species complex: an update. Diagn Microbiol Infect Dis. 2016;84(1):87–94.
  • Dos Santos PO, Rodrigues AM, Fernandes GF, et al. Immunodiagnosis of paracoccidioidomycosis due to Paracoccidioides brasiliensis using a latex test: detection of specific antibody anti-gp43 and specific antigen gp43. PLoS Negl Trop Dis. 2015;9(2):e0003516.
  • Gaviria M, Rivera V, Muñoz-Cadavid C, et al. Validation and clinical application of a nested PCR for paracoccidioidomycosis diagnosis in clinical samples from Colombian patients. Braz J Infect Dis. 2015;19(4):376–383.
  • Garcia Garcia SC, Salas Alanis JC, Flores MG, et al. Coccidioidomycosis and the skin: a comprehensive review. An Bras Dermatol. 2015;90:610–619.
  • Freedman M, Jackson BR, McCotter O, et al. Coccidioidomycosis outbreaks, United States and Worldwide, 1940-2015. Emerg Infect Dis. 2018;24(3):417–423.
  • McCotter OZ, Benedict K, Engelthaler DM, et al. Update on the epidemiology of coccidioidomycosis in the United States. Med Mycol. 2019;57(Supplement_1):S30–S40.
  • Wilson L, Ting J, Lin H, et al. The rise of valley fever: prevalence and cost burden of coccidioidomycosis infection in California. Int J Environ Res Public Health. 2019;16(7):pii: E1113.
  • Laniado-Laborín R, Arathoon EG, Canteros C, et al. Coccidioidomycosis in Latin America. Med Mycol. 2019;57(Supplement_1):S46‐S55.
  • Toda M, Gonzalez FJ, Fonseca-Ford M, et al. Notes from the field: multistate coccidioidomycosis outbreak in U.S. residents returning from community service trips to Baja California, Mexico — july–August 2018. MMWR Morb Mortal Wkly Rep. 2019;68(14):332–333.
  • Lacy GH, Swatek FE. Soil ecology of coccidioides immitis at Amerindian middens in California. Appl Microbiol. 1974;27(2):379–388.
  • Mendoza N, Noel P, Blair JE. Diagnosis, treatment, and outcomes of coccidioidomycosis in allogeneic stem cell transplantation. Transpl Infect Dis. 2015;17(3):380–388.
  • Koistinen K, Mullaney L, Bell T, et al. Coccidioidomycosis in nonhuman primates: pathologic and clinical findings. Vet Pathol. 2018;55(6):905–915.
  • de Aguiar Cordeiro R, Patoilo KR, Praciano SB, et al. Antigens of coccidioides posadasii as an important tool for the immunodiagnosis of coccidioidomycosis. Mycopathologia. 2013;175(1–2):25–32.
  • Johnson R, Kernerman SM, Sawtelle BG, et al. A reformulated spherule-derived coccidioidin (Spherusol) to detect delayed-type hypersensitivity in coccidioidomycosis. Mycopathologia. 2012;174(5–6):353–358.
  • Saubolle MA, Wojack BR, Wertheimer AM, et al. Multicenter clinical validation of a cartridge-based real-time PCR system for detection of coccidioides spp. in lower respiratory specimens. J Clin Microbiol. 2018;56:pii: e01277–17.
  • Bowers JR, Parise KL, Kelley EJ, et al. Direct detection of coccidioides from arizona soils using CocciENV, a highly sensitive and specific real-time PCR assay. Med Mycol. 2019;57(2):246–255.
  • Pappagianis D. Serologic studies in coccidioidomycosis. Semin Respir Infect. 2001;16(4):242–250.
  • Mendoza N, Blair JE. The utility of diagnostic testing for active coccidioidomycosis in solid organ transplant recipients. Am J Transplant. 2013;13(4):1034–1039.
  • Kaufman L. Laboratory methods for the diagnosis and confirmation of systemic mycoses. Clin Infect Dis. 1992;14(Suppl 1):S23–9.
  • Kaufman L, Clark MJ. Value of the concomitant use of complement fixation and immunodiffusion tests in the diagnosis of coccidioidomycosis. Appl Microbiol. 1974;28(4):641–643.
  • Blair JE, Ampel NM, Hoover SE. Coccidioidomycosis in selected immunosuppressed hosts. Med Mycol. 2019 Feb 1;57(Supplement_1):S56–S63.
  • Malo J, Holbrook E, Zangeneh T, et al. Comparison of three anti-coccidioides antibody enzyme immunoassay kits for the diagnosis of coccidioidomycosis. Med Mycol. 2020; pii: myz125. doi:10.1093/mmy/myz125
  • Schwartz IS, Kauffman CA. Blastomycosis. Semin Respir Crit Care Med. 2020;41(1):31–41.
  • Ashraf N, Kubat RC, Poplin V, et al. Re-drawing the maps for endemic mycoses. Mycopathologia. 2020. Feb 10. doi: 10.1007/s11046-020-00431-2
  • Ireland M, Klumb C, Smith K, et al. Blastomycosis in Minnesota, USA, 1999-2018. Emerg Infect Dis. 2020;26(5):866–875.
  • Saccente M, Woods GL. Clinical and laboratory update on blastomycosis. Clin Microbiol Rev. 2010 Apr;23(2):367–381.
  • Khuu D, Shafir S, Bristow B, et al. Blastomycosis mortality rates, United States, 1990–2010. Emerg Infect Dis. 2014 Nov;20(11):1789–1794.
  • Castillo CG, Kauffman CA, Miceli MH. Blastomycosis. Infect Dis Clin North Am. 2016;30(1):247‐264.
  • Schwartz IS, Wiederhold NP, Hanson KE, et al. Blastomyces helicus, a New Dimorphic Fungus Causing Fatal Pulmonary and Systemic Disease in Humans and Animals in Western Canada and the United States. Clin Infect Dis. 2019;68(2):188‐195.
  • Friedman DZP, Schwartz IS. Emerging fungal infections: new patients, new patterns, and new pathogens. J Fungi (Basel). 2019;5(3):67.
  • Richer SM, Smedema ML, Durkin MM, et al. Development of a highly sensitive and specific blastomycosis antibody enzyme immunoassay using Blastomyces dermatitidis surface protein BAD-1. Clin Vaccine Immunol. 2014;21(2):143‐146.
  • Li L, Chen K, Dhungana N, et al. Characterization of clinical isolates of talaromyces marneffei and related species, California, USA. Emerg Infect Dis. 2019;25(9):1765‐1768.
  • Chan JF, Lau SK, Yuen KY, et al. Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients. Emerg Microbes Infect. 2016;5(1):e19.
  • Li Q, Wang C, Zeng K, et al. AIDS-associated disseminated talaromycosis (penicilliosis) marneffei. J Dtsch Dermatol Ges. 2018;16(10):1256‐1259.
  • Cao C, Xi L, Chaturvedi V. Talaromycosis (Penicilliosis) due to talaromyces (penicillium) marneffei: insights into the clinical trends of a major fungal disease 60 years after the discovery of the pathogen. Mycopathologia. 2019;184(6):709‐720.
  • Xian J, Huang X, Li Q, et al. Dermatoscopy for the rapid diagnosis of talaromyces marneffei infection: a case report. BMC Infect Dis. 2019;19(1):707.
  • Ning C, Lai J, Wei W, et al. Accuracy of rapid diagnosis of talaromyces marneffei: A systematic review and meta-analysis. PLoS One. 2018;13(4):e0195569.
  • Lau SK, Lam CS, Ngan AH, et al. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for rapid identification of mold and yeast cultures of Penicillium marneffei. BMC Microbiol. 2016;16(1):36.
  • Pruksaphon K, Intaramat A, Ratanabanangkoon K, et al. Diagnostic laboratory immunology for talaromycosis (penicilliosis): review from the bench-top techniques to the point-of-care testing. Diagn Microbiol Infect Dis. 2020;96(3):114959.
  • Li X, Zheng Y, Wu F, et al. Evaluation of quantitative real-time PCR and platelia galactomannan assays for the diagnosis of disseminated talaromyces marneffei infection. Med Mycol. 2020;58(2):181‐186.
  • Pruksaphon K, Intaramat A, Ratanabanangkoon K, et al. Development and characterization of an immunochromatographic test for the rapid diagnosis of talaromyces (penicillium) marneffei. PLoS One. 2018;13(4):e0195596.
  • Mendes MO, Moraes MA, Renoiner EI, et al. Acute conjunctivitis with episcleritis and anterior uveitis linked to adiaspiromycosis and freshwater sponges, Amazon region, Brazil, 2005. Emerg Infect Dis. 2009;15(4):633‐639.
  • Turner D, Burke M, Bashe E, et al. Pulmonary adiaspiromycosis in a patient with acquired immunodeficiency syndrome. Eur J Clin Microbiol Infect Dis. 1999;18(12):893‐895.
  • Pelegrín I, Ayats J, Xiol X, et al. Disseminated adiaspiromycosis: case report of a liver transplant patient with human immunodeficiency infection, and literature review. Transpl Infect Dis. 2011;13(5):507‐514.
  • Schwartz IS, Sanche S, Wiederhold NP, et al. Emergomyces canadensis, a dimorphic fungus causing fatal systemic human disease in North America. Emerg Infect Dis. 2018;24(4):758‐761.
  • Maphanga TG, Britz E, Zulu TG, et al. In vitro antifungal susceptibility of yeast and mold phases of isolates of dimorphic fungal pathogen emergomyces africanus (formerly emmonsia sp.) from HIV-infected South African Patients. J Clin Microbiol. 2017;55(6):1812‐1820.
  • Wang P, Kenyon C, de Hoog S, et al. A novel dimorphic pathogen, emergomyces orientalis (Onygenales), agent of disseminated infection. Mycoses. 2017;60(5):310‐319.
  • Rooms I, Mugisha P, Gambichler T, et al. Disseminated emergomycosis in a person with HIV Infection, Uganda. Emerg Infect Dis. 2019;25(9):1750‐1751.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.